Bavarian Nordic expands vaccine contract by $234mBavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options. more ➔
Genfit swallows Versantis in €105m dealThrough the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio. more ➔
Food specialist Standing Ovation SA raises €12mFoodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures. more ➔
HeartBeat.bio inks partnership with Molecular DevicesHeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening more ➔
Mobile app recognises COVID-19 infectionDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings. more ➔
Pleco Therapeutics raises €17.3m in Series ADutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval. more ➔
Emergence Therapeutics licences Synaffix platformSynaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence. more ➔
Abivax SA Abivax SA bags €49.2m to push ABX-464Paris-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors. more ➔
BioEcho Life Sciences launches US subsidiaryGerman nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market. more ➔ more ➔
Belgian researchers create extraembryonic mesoderm cellsResearchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects. more ➔
Abivax SA
